1. In General
1.1. World Health Organization
1.1.1. Disease Commodity Package
1.1.2. National Capacity Tool
1.1.3. Surveillance Guidance
1.1.4. Water Sanitation
1.2. USA
1.2.1. Contact Tracing
1.3. Other Countries
1.3.1. China
1.3.1.1. Clinical Characteristics
1.3.1.2. Treatment
1.3.2. Italy
1.3.2.1. ICU Status Dr. Vergano
1.3.2.2. Italian PICU experience
1.3.2.3. Intensivist Interview
1.3.2.4. Airway Management Recommendations
1.3.3. United Kingdom
1.4. Immunology
1.4.1. COVID-19 Antibody Responses
1.4.2. Duration of Antibody Response (SARS)
1.4.3. Antibody Test Expectation
1.4.4. Immunity in Rhesus Monkeys
1.4.5. COVID+ After Recovery
1.4.6. COVID-19 Pathophysiology
2. Patient Care
2.1. Medical Management
2.1.1. Resuscitation
2.1.1.1. BLS COVID Consensus
2.1.1.2. BLS 1 Rescuer
2.1.1.3. BLS ≥2 Rescuers
2.1.1.4. PALS COVID Algorithm
2.1.1.5. PALS COVID Consensus
2.1.2. Blood Management
2.1.3. World Health Organization
2.1.4. Harvard Medical Grand Rounds
2.1.5. Patient Populations
2.1.5.1. Pregnancy
2.1.5.2. Children
2.1.5.3. Hypertension
2.1.6. British Journal of Anesthesia
2.2. Chinese Medicine
2.3. Peri-Operative
2.3.1. Principles of Airway Management
2.3.2. Intubation Precautions
2.4. OR into ICU
2.4.1. Dräger
2.4.2. Society of Critical Care Medicine
2.4.3. ASA & APSF
3. Provider Care
3.1. World Health Organization
3.1.1. Rational Use PPE
3.1.2. Questions and Answers
3.2. Wellness
3.2.1. American Society of Anesthesiologists
3.2.2. Intensive Care Society
3.3. PPE
3.3.1. Food Drug Administration
3.3.2. APSF Recommendations
3.3.3. ASA